Merck & Co. has won U.S. Food and Drug Administration priority review for its application seeking expanded use of its Welireg oral cancer drug in patients with rare tumors that form in and around the ...
Merck & Co (NYSE:MRK)., the second-largest U.S. drugmaker by revenue, is facing a jury trial over accusations that it ...
Hosted on MSN59m
Belén Garijo, CEO of Merck: "Regulation is getting worse and there is a total disconnect between the EU and the States. Europe is at stake"The Spanish CEO of the German giant: "I saw Sánchez in a closed-door meeting in Davos very much in line with Von der Leyen on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback